Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry-Reference-Cited by-同舟云学术

Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry

Published:2024-09-15 Issue:6 Volume:210 Page:801-813
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

King Christopher S.¹,Ignacio Rosalinda V.²,Khangoora Vikramjit¹,Nyquist Alan¹,Singhal Anju¹,Thomas Christopher¹,Cantres Onix Fonseca¹,Aryal Shambhu¹,Shlobin Oksana A.¹,Flaherty Kevin³,Lasky Joseph⁴,Nathan Steven D.¹

Affiliation:

1. Advanced Lung Disease and Transplant Program, Inova Fairfax Medical Center, Falls Church, Virginia;

2. Department of Biostatistics and

3. Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan; and

4. Department of Pulmonary and Critical Care Medicine, Tulane School of Medicine, New Orleans, Louisiana

Publisher

American Thoracic Society

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.202309-1708OC

Reference17 articles.

1. Interstitial lung diseases

2. Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment – a German claims data analysis

3. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening

4. Hospitalizations in patients with idiopathic pulmonary fibrosis

5. Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospitalizations as Clinical Trials Endpoint in Interstitial Lung Disease: Are We There Yet?;American Journal of Respiratory and Critical Care Medicine;2024-09-15

2. The impact of antifibrotic use on long-term clinical outcomes in the pulmonary fibrosis foundation registry;Respiratory Research;2024-06-21